$52.3 Million is the total value of SVB FINANCIAL GROUP's 28 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 400.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ORCHESTRA BIOMED HOLDINGS INC | $2,486,721 | – | 127,068 | +100.0% | 4.76% | – | |
| FROG | Buy | JFROG LTD | $1,876,455 | +17.0% | 95,251 | +26.7% | 3.59% | -18.1% |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $841,048 | – | 35,353 | +100.0% | 1.61% | – | |
| PATH | New | UIPATH INCcl a | $790,709 | – | 45,029 | +100.0% | 1.51% | – |
| New | MOVELLA HOLDINGS INC | $75,575 | – | 55,570 | +100.0% | 0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COINBASE GLOBAL INC | 4 | Q3 2023 | 57.5% |
| OKTA INC | 4 | Q3 2023 | 20.9% |
| ROOT INC | 4 | Q3 2023 | 14.0% |
| AXSOME THERAPEUTICS INC | 4 | Q3 2023 | 7.1% |
| CAREMAX INC | 4 | Q3 2023 | 3.0% |
| PLANET LABS PBC | 4 | Q3 2023 | 2.0% |
| MOONLAKE IMMUNOTHERAPEUTICS | 4 | Q3 2023 | 1.7% |
| ROVER GROUP INC | 4 | Q3 2023 | 1.2% |
| CULLINAN ONCOLOGY INC | 4 | Q3 2023 | 0.8% |
| CARIBOU BIOSCIENCES INC | 4 | Q3 2023 | 0.8% |
View SVB FINANCIAL GROUP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | February 10, 2023 | 1,716,764 | 8.8% |
| Root, Inc. | February 10, 2023 | 783,012 | 8.6% |
| BigCommerce Holdings, Inc. | February 12, 2021 | 392,224 | 0.6% |
| ISC8 INC. /DE | February 17, 2015 | 34,533,213 | 11.9% |
View SVB FINANCIAL GROUP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 8-K | 2024-03-22 |
| 8-K | 2024-03-20 |
| 8-K | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 8-K | 2024-02-09 |
| 8-K | 2024-02-01 |
| 8-K | 2024-01-29 |
| SC 13G/A | 2024-01-17 |
| 8-K | 2024-01-10 |
View SVB FINANCIAL GROUP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.